Cannovation Clinical Research Partners

Name

Cannovation Clinical Research Partners

Legal name

CCRP Partners, LLC

Website

https://cannovationcrp.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Cannovation Clinical Research Partners (CCRP) is a U.S.-based, full-service clinical research organization and consulting firm specializing in cannabinoid and psychedelic (Schedule I-V) therapeutic development. It serves pharma, biotech, universities, DEA-licensed researchers, and nutraceutical firms with end-to-end preclinical, clinical, regulatory, and commercialization services.

Ownership category

akta.pro rank

Product category

Clinical Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical research services
• Pharmaceutical consulting
• Drug development services
• Regulatory strategy consulting
• Schedule I drug development

Headquarters

HQ city

Buford

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. CRO Consulting Services: Full-service clinical research organization and consulting firm providing end-to-end strategic partnership services from business planning to preclinical/clinical development, regulatory approval, and commercialization. Revenue is generated through professional services engagements with pharmaceutical companies, universities, and DEA-licensed researchers.
2. Specialized Service Offerings: Cannovation offers targeted consulting services including global strategic planning for R&D and commercialization, DEA/regulatory/legal strategy, material sourcing and manufacturing support, GMP/QA/QC/QP support, licensing guidance, business planning and market entry, product commercialization, and project management. These are billed as individual consulting engagements.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Cannovation Clinical Research Partners is a full-service clinical research organization (CRO) and consulting firm providing end-to-end strategic partnership services from business planning through preclinical and clinical development (Phases I-IV), regulatory approval, and commercialization. The company delivers services across three specialized divisions covering traditional drug development (rare diseases, medical devices, animal health), psychedelic-based therapeutics, and cannabis-derived novel therapeutics, supported by eleven consulting service lines spanning R&D strategy, DEA/regulatory/legal affairs, manufacturing, supply chain, GMP/QA/QC, licensing, market entry, and project management.

Product overview

Cannovation Clinical Research Partners (CCRP) is a U.S.-based full-service clinical research organization (CRO) and consulting firm offering a platform-plus-services architecture. The company provides end-to-end strategic partnership services from business planning to preclinical/clinical development, regulatory approval, and commercialization or exit. CCRP operates through three specialized divisions: (1) Traditional Drug Development for rare diseases, medical devices, and animal health; (2) Psychedelic-Based Drug Development; and (3) Cannabis-Derived Novel Therapeutics. The service portfolio includes 11 core consulting services spanning Global Strategic Planning, R&D Execution, DEA/Regulatory/Legal Strategy, Material Sourcing, Supply Chain/Packaging, GMP/QA/QC/QP Support, Licensing Guidance, Business Planning/Market Entry, Product Commercialization, Project Management, and Psychedelic Legal Strategy. In December 2025, CCRP launched an integrated platform with partner Benuvia Manufacturing combining CRO services with GMP manufacturing for Schedule I-V controlled substances.

Differentiator

Problem solved

Functional benefit

Products and services

• Global Strategic Planning for R, D & C Expert guidance navigating pharmaceutical and biotechnology research, development, and commercialization complexities to develop robust plans optimizing product performance and meeting regulatory standards, targeted at pharma and biotech clients.
• Research & Development Plan Execution Comprehensive R&D execution covering formulation development, regulatory compliance, clinical trial design and management, quality assurance, market analysis, and supply chain optimization for pharma and biotech clients.
• DEA, Regulatory & Legal Strategy Navigation of FDA, NIH, DEA, and other regulatory frameworks through development of regulatory roadmaps, pre-submission meetings, and pre-IND meeting processes, targeted at drug developers in regulated categories.
• Material Sourcing & Manufacturing Manufacturing process optimization, supply chain management, regulatory compliance, and material sourcing strategies including ethical sourcing guidance for biotech and pharmaceutical clients.
• Supply Chain & Packaging Strategy Supply chain streamlining ensuring reliability, efficiency, and compliance, with import/export guidance, supply chain strategy, drug sourcing, and packaging regulation navigation for pharmaceutical clients.
• GMP, QA, QC, QP Support Achievement of excellence in Good Manufacturing Practices (GMP), Quality Assurance (QA), Quality Control (QC), and Quality Product Release (QP) within the cannabinoid pharmaceutical and biotechnology industries.
• Licensing Guidance & Consultation Navigation of licensing processes in pharmaceutical, biotech, and legal state cannabis markets, from initial application through ongoing compliance, for pharma and cannabis clients.
• Business Planning & Market Entry Comprehensive business planning and market entry strategies in cannabinoid pharmaceutical and biotech industries, including market research, competitive intelligence, landscape analysis, business model development, and go-to-market strategies.
• Product Commercialization End-to-end product commercialization assistance for pharmaceuticals, biotech, and OTC products, from concept development through market launch and beyond.
• Project Management Expert project management services for cannabis research and product development, overseeing planning, resource allocation, execution, and delivery while ensuring schedule, budget, and quality compliance.
• Psychedelic Legal Strategy Guidance through the complex legal landscape surrounding psychedelics, including DEA and FDA regulatory requirements, strategic roadmaps, risk mitigation, and market entry support for licensing and compliance.
• Traditional Drug Development Division Clinical research services for rare diseases, medical devices, and animal health, including business planning, preclinical and clinical research phases 1-4, all therapeutic classes, and regulatory pathways, organized as one of three divisions.
• Psychedelic-Based Drug Development Division End-to-end development services for psychedelic therapeutics including prescription drugs and nutraceuticals with U.S. and global regulatory strategy expertise, organized as one of three divisions.
• Cannabis-Derived Novel Therapeutics Division Specialized development services for cannabis-derived novel therapeutics and products, including THC, CBD, CBG-based prescription and non-prescription applications, organized as one of three divisions.
• Cannovation-Benuvia Integrated CRO and Manufacturing Platform Industry's first fully integrated CRO and manufacturing platform for controlled substances, uniting preclinical and clinical research, regulatory strategy, and global commercialization with DEA Schedule I-V drug manufacturing, analytical testing, and CMC development for pharmaceutical and biotech sponsors.

Quantifiable outcome

• Streamlined IND-to-trial transfer with unified regulatory oversight
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Benuvia ManufacturingcoreStrategic or Co-development Partner · 3 December 2025Strategic partnership to create the industry's first fully integrated CRO and manufacturing platform for controlled substances. Unites Cannovation's expertise in preclinical and clinical research, regulatory strategy, and global commercialization with Benuvia's end-to-end capabilities in DEA Schedule I-V drug manufacturing, analytical testing, and CMC development. Together, the companies offer pharmaceutical and biotech sponsors a single, compliant pathway from molecule to market for cannabinoid, psychedelic, and novel CNS therapeutics. Benefits include streamlined IND-to-trial transfer with unified regulatory oversight, accelerated timelines through reduced vendor friction, access to global trial networks across North America, Europe, and Latin America, DEA-licensed manufacturing for Schedule I-V substances including psilocybin, LSD, and DMT, and comprehensive commercialization strategies.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cannovation-clinical-research-partners

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannovation Clinical Research Partners